143,024 members

Skip to content. | Skip to navigation

News

Cost-effective migraine drug could benefit 10,000

 

Start sharing

If you've got news you'd like to share, let us know and we'll consider it for our news section.
 

Cost-effective migraine drug could benefit 10,000

NICE has published final draft guidance which recommends fremanezumab (also called Ajovy and made by Teva Pharmaceuticals) for preventing chronic migraine.

NICE says 10,000 people could benefit from the “cost-effective” drug. More....